Delivery Order SPE2DB25D3404-SPE2DB25FULYW

Award Date 2/7/25
Potential Completion Date 2/10/25
Potential Value $2.3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,842.19, is a delivery order for the supply of Ceftriaxone 1 GM-D5W bags. The contract has a period of performance through December 5, 2024 and utilizes a firm fixed-price pricing structure. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,578.30 firm fixed-price delivery order contract is for the supply of 4,567,142,436 units of Ceftriaxone 2 GM-D5W bags, a critical pharmaceutical product. The contract has an ultimate completion date of February 5, 2025 and was awarded on February 4, 2025. Amerisourcebergen holds a significant $999,999,999...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of ceftriaxone 2 GM-D5W bags. The firm-fixed-price delivery order, valued at $1,461.92, has an ultimate completion date of August 14, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $12,708.66, is a delivery order for the supply of 4,566,280,995 units of ceftriaxone 2 GM-D5W bags, a critical antibiotic medication. The contract has an ultimate completion date of October 31, 2024 and is structured as a firm fixed-price delivery order. This award is not designated as a...
This is a federal contract award from the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,445.31, is for the delivery of Ceftriaxone 1 GM-D5W bags, a critical antibiotic medication. The contract is a Firm Fixed Price Delivery Order with a completion date of January 24, 2025. This award is not associated with a set-aside designation, indicating...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a Delivery Order under the umbrella of a larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $3,573.38, is for the delivery of CEFTRIAXONE 2 GM-D5W BAGS, a critical medical supply. The contract has no set-aside designation, indicating open competition. Amerisourcebergen holds a significant $999,999,999 IDC with the DLA,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,477.10 fixed-price delivery order is for the supply of Ceftriaxone 2 GM-D5W bags, a critical antibiotic medication. The contract has an ultimate completion date of December 17, 2024 and was awarded on December 16, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,149.11 firm fixed-price delivery order is for the supply of Ceftriaxone 1 GM-D5W bags, a critical antibiotic medication. The contract has a period of performance through December 17, 2024 and was awarded on December 16, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery...
This federal contract award, valued at $3,589.90, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is a firm fixed price delivery order for the supply of 4,563,980,514 units of the pharmaceutical product Ceftriaxone 2 gm-D5W bags. This award does not have a set-aside designation. Amerisourcebergen Drug Corp is the prime contractor and is responsible for delivering these medical supplies to support the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to provide 4,566,070,261 units of Ceftriaxone 1 GM-D5W Bags. The firm-fixed-price delivery order, valued at $4,557.82, is not set aside for any specific business category. The award is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and DLA Troop Support Medical, worth up to $999,999,999 through December 2025, for...
  • SPE2DB25D3404
    Indefinite Delivery Contract
  • SPE2DB25D3404-SPE2DB25FULYW
    Delivery Order

This federal contract award, valued at $2,266.53, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, which is a delivery order, is for the supply of Ceftriaxone 1 GM-D5W bags, a critical pharmaceutical product. No set-aside designation was used for this contract.

AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, which covers similar medical products and prescription drugs. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies, serving the healthcare needs of military personnel, veterans, and other federal beneficiaries through a streamlined, comprehensive contracting mechanism.

Generated 5/9/25, 9:54 AM